• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Financing of Vaccine Delivery in Primary Care Practices.初级保健实践中的疫苗接种融资。
Acad Pediatr. 2017 Sep-Oct;17(7):770-777. doi: 10.1016/j.acap.2017.06.001. Epub 2017 Jun 7.
2
Vaccine financing and billing in practices serving adult patients: A follow-up survey.成人患者就诊的医疗机构中的疫苗筹资和计费:一项后续调查。
Vaccine. 2018 Feb 14;36(8):1093-1100. doi: 10.1016/j.vaccine.2018.01.015.
3
Primary care physician perspectives on reimbursement for childhood immunizations.初级保健医生对儿童免疫接种报销的看法。
Pediatrics. 2009 Dec;124 Suppl 5:S466-71. doi: 10.1542/peds.2009-1542F.
4
Net financial gain or loss from vaccination in pediatric medical practices.儿科医疗实践中疫苗接种的净财务收益或损失。
Pediatrics. 2009 Dec;124 Suppl 5:S472-91. doi: 10.1542/peds.2009-1542G.
5
Primary care physician perspectives on reimbursement for childhood immunizations.基层医疗医生对儿童免疫接种报销的看法。
Pediatrics. 2008 Dec;122(6):1319-24. doi: 10.1542/peds.2008-2033.
6
Variation in provider vaccine purchase prices and payer reimbursement.供应商疫苗采购价格和支付方报销的差异。
Pediatrics. 2009 Dec;124 Suppl 5:S459-65. doi: 10.1542/peds.2009-1542E.
7
Vaccine financing from the perspective of primary care physicians.从基层医生的角度看疫苗融资。
Pediatrics. 2014 Mar;133(3):367-74. doi: 10.1542/peds.2013-2637. Epub 2014 Feb 24.
8
Cost of vaccine administration among pediatric practices.儿科诊所的疫苗接种成本。
Pediatrics. 2009 Dec;124 Suppl 5:S492-8. doi: 10.1542/peds.2009-1542H.
9
Variation in provider vaccine purchase prices and payer reimbursement.供应商疫苗采购价格和支付方报销的差异。
Pediatrics. 2008 Dec;122(6):1325-31. doi: 10.1542/peds.2008-2038.
10
Private-sector vaccine purchase costs and insurer payments: a disincentive for using combination vaccines?私营部门疫苗采购成本与保险公司支付费用:使用联合疫苗的阻碍因素?
Hum Vaccin. 2011 Apr;7(4):426-8. doi: 10.4161/hv.7.4.14122. Epub 2011 Apr 1.

引用本文的文献

1
Jurisdiction-level costs of the initial phase of the COVID-19 vaccination program in the United States, December 20, 2020-May 31, 2021.2020 年 12 月 20 日至 2021 年 5 月 31 日美国 COVID-19 疫苗接种计划初始阶段的管辖范围成本。
Vaccine. 2024 Oct 24;42(24):126287. doi: 10.1016/j.vaccine.2024.126287. Epub 2024 Sep 3.
2
Reimbursement for HPV Vaccine Cost in the Private Sector: A Comparison Across Specialties.私营部门 HPV 疫苗费用报销:各专业比较。
Ann Fam Med. 2023 Jul-Aug;21(4):344-346. doi: 10.1370/afm.2990.
3
Effect of State Immunization Information System Based Reminder/Recall for Influenza Vaccinations: A Randomized Trial of Autodialer, Text, and Mailed Messages.基于国家免疫信息系统的流感疫苗接种提醒/召回效果:自动拨号、短信和邮件消息的随机试验。
J Pediatr. 2020 Jun;221:123-131.e4. doi: 10.1016/j.jpeds.2020.02.020.
4
Pediatricians' Experiences With and Perceptions of the Vaccines for Children Program.儿科医生在儿童疫苗计划中的经验和看法。
Pediatrics. 2020 Mar;145(3). doi: 10.1542/peds.2019-1207. Epub 2020 Feb 21.
5
Strategies for the elimination of hepatitis C virus infection as a public health threat in the United States.在美国将丙型肝炎病毒感染作为公共卫生威胁予以消除的策略。
Curr Hepatol Rep. 2018 Jun;17(2):111-120. doi: 10.1007/s11901-018-0394-x. Epub 2018 Mar 24.

本文引用的文献

1
Vaccine financing from the perspective of primary care physicians.从基层医生的角度看疫苗融资。
Pediatrics. 2014 Mar;133(3):367-74. doi: 10.1542/peds.2013-2637. Epub 2014 Feb 24.
2
Vaccines provided by family physicians.家庭医生提供的疫苗。
Ann Fam Med. 2010 Nov-Dec;8(6):507-10. doi: 10.1370/afm.1185.
3
Trends in well-child visits to family physicians by children younger than 2 years of age.2 岁以下儿童接受家庭医生常规儿童保健就诊的趋势。
Ann Fam Med. 2010 May-Jun;8(3):245-8. doi: 10.1370/afm.1076.
4
Vaccine finance resources for physicians.面向医生的疫苗资金资源。
Pediatrics. 2009 Dec;124 Suppl 5:S573-6. doi: 10.1542/peds.2009-1542V.
5
Financing vaccination of children and adolescents: National Vaccine Advisory Committee recommendations.儿童和青少年疫苗接种的资金筹集:国家疫苗咨询委员会的建议。
Pediatrics. 2009 Dec;124 Suppl 5:S558-62. doi: 10.1542/peds.2009-1542P.
6
Financing the delivery of vaccines to children and adolescents: challenges to the current system.为儿童和青少年提供疫苗融资:当前体系面临的挑战。
Pediatrics. 2009 Dec;124 Suppl 5:S548-57. doi: 10.1542/peds.2009-1542O.
7
Cost of vaccine administration among pediatric practices.儿科诊所的疫苗接种成本。
Pediatrics. 2009 Dec;124 Suppl 5:S492-8. doi: 10.1542/peds.2009-1542H.
8
Net financial gain or loss from vaccination in pediatric medical practices.儿科医疗实践中疫苗接种的净财务收益或损失。
Pediatrics. 2009 Dec;124 Suppl 5:S472-91. doi: 10.1542/peds.2009-1542G.
9
Variation in provider vaccine purchase prices and payer reimbursement.供应商疫苗采购价格和支付方报销的差异。
Pediatrics. 2009 Dec;124 Suppl 5:S459-65. doi: 10.1542/peds.2009-1542E.
10
Immunization financing: key area for American Academy of Pediatrics advocacy.免疫接种融资:美国儿科学会倡导的关键领域。
Pediatrics. 2009 Dec;124 Suppl 5:S455-6. doi: 10.1542/peds.2009-1542C.

初级保健实践中的疫苗接种融资。

Financing of Vaccine Delivery in Primary Care Practices.

机构信息

Department of Pediatrics, University of Colorado Anschutz Medical Campus, Children's Hospital Colorado, Aurora; Adult and Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado Anschutz Medical Campus, Children's Hospital Colorado, Aurora.

Department of Pediatrics, University of Colorado Anschutz Medical Campus, Children's Hospital Colorado, Aurora; Adult and Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado Anschutz Medical Campus, Children's Hospital Colorado, Aurora.

出版信息

Acad Pediatr. 2017 Sep-Oct;17(7):770-777. doi: 10.1016/j.acap.2017.06.001. Epub 2017 Jun 7.

DOI:10.1016/j.acap.2017.06.001
PMID:28600199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5600475/
Abstract

OBJECTIVE

Vaccines represent a significant portion of primary care practice expenses. Our objectives were to determine among pediatric (Ped) and family medicine (FM) practices: 1) relative payment for vaccine purchase and administration and estimated profit margin according to payer type, 2) strategies used to reduce vaccine purchase costs and increase payment, and 3) whether practices have stopped providing vaccines because of finances.

METHODS

A national survey conducted from April through September 2011 among Ped and FM practitioners in private, single-specialty practices.

RESULTS

The response rate was 51% (221 of 430). Depending on payer type, 61% to 79% of practices reported that payment for vaccine purchase was at least 100% of purchase price and 34% to 74% reported that payment for vaccine administration was at least $11. Reported strategies to reduce vaccine purchase cost were online purchasing (81% Ped, 36% FM), prompt pay (78% Ped, 49% FM), and bulk order (65% Ped, 49% FM) discounts. Fewer than half of practices used strategies to increase payment; in a multivariable analysis, practices with ≥5 providers were more likely to use strategies compared with practices with fewer providers (adjusted odds ratio, 2.65; 95% confidence interval, 1.51-4.62). When asked if they had stopped purchasing vaccines because of financial concerns, 12% of Ped practices and 23% of FM practices responded 'yes,' and 24% of Ped and 26% of FM practices responded 'no, but have seriously considered.'

CONCLUSIONS

Practices report variable payment for vaccination services from different payer types. Practices might benefit from increased use of strategies to reduce vaccine purchase costs and increase payment for vaccine delivery.

摘要

目的

疫苗在初级保健实践费用中占很大比例。我们的目标是确定儿科 (Ped) 和家庭医学 (FM) 实践:1)根据付款人类型确定疫苗购买和管理的相对付款额和估计利润率,2)用于降低疫苗购买成本和增加付款的策略,以及 3)实践是否因财务问题停止提供疫苗。

方法

2011 年 4 月至 9 月期间,对私人单一专业实践中的儿科和家庭医学从业者进行了一项全国性调查。

结果

回应率为 51%(221/430)。根据付款人类型,61%至 79%的实践报告称疫苗购买的付款至少为购买价格的 100%,34%至 74%的实践报告称疫苗接种的付款至少为 11 美元。报告的降低疫苗购买成本的策略包括在线购买(81%的儿科,36%的家庭医学),及时付款(78%的儿科,49%的家庭医学)和批量订购(65%的儿科,49%的家庭医学)折扣。不到一半的实践使用增加付款的策略;在多变量分析中,与拥有较少提供者的实践相比,拥有≥5 名提供者的实践更有可能使用策略(调整后的优势比,2.65;95%置信区间,1.51-4.62)。当被问及是否因财务问题停止购买疫苗时,12%的儿科实践和 23%的家庭医学实践回答“是”,24%的儿科和 26%的家庭医学实践回答“否,但已认真考虑”。

结论

实践报告不同付款人类型的疫苗接种服务支付情况存在差异。实践可能受益于增加使用降低疫苗购买成本和增加疫苗接种付款的策略。